FIELD: medicine.
SUBSTANCE: composition for treatment of dry eyes syndrome associated with nucleic acids, which develops as a result of nucleic acids formation/generation together with formation of eye mucoid films and/or biofilms, contains deoxyribonuclease I (DNAase I) and ophthalmologic auxiliary substance, and does not contain antibiotics. The composition is applied to the eye surface to remove the nucleic acid from the eye surface. Also, a method for treatment of the said dry eyes syndrome is provided, comprising administration of the said composition to the eye in an effective amount.
EFFECT: application of the group of inventions improves treatment of the dry eyes syndrome associated with nucleic acids, which develops as a result of formation, generation of nucleic acids together with formation of eye mucoid films or biofilms.
13 cl, 16 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING THE EFFECTIVENESS OF TREATMENT OF DRY EYE SYNDROME IN PATIENTS WITH DIABETES MELLITUS | 2020 |
|
RU2740363C1 |
| THERAPEUTIC RECOVERY AND ENHANCEMENT OF OCULAR SURFACE WETTING | 2009 |
|
RU2510274C2 |
| METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISEASES | 2016 |
|
RU2691412C2 |
| RECOMBINANT RNA FRAGMENT (VARIANTS), RIBONUCLEOPROTEID COMPLEX (VARIANTS), PLASMID | 1990 |
|
RU2132877C1 |
| METHOD OF EXTRACTING EXTRACELLULAR DEOXYRIBONUCLEIC ACID FROM BLOOD | 2008 |
|
RU2372405C1 |
| SCALE PRODUCTION METHOD OF PRODUCING RECOMBINANT LENTIVIRAL VECTORS IN CELL CULTURE SYSTEM IN SERUM-FREE SUSPENSION | 2014 |
|
RU2709678C2 |
| METHOD OF TREATING PATIENTS AFTER AGE-RELATED CATARACT PHACOEMULSIFICATION | 2019 |
|
RU2710553C1 |
| VECTORS CONTAINING SPACER/FILLER POLYNUCLEOTIDE SEQUENCES, AND METHODS OF USING THEM | 2014 |
|
RU2725813C2 |
| Aeromonas bestiarum BACTERIA STRAIN - PRODUCER OF ALKALINE RIBONUCLEASE HAVING ANTIVIRAL ACTIVITY | 2013 |
|
RU2520086C1 |
| METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIA B | 2011 |
|
RU2608643C2 |
